期刊
JOURNAL OF EMERGENCY MEDICINE
卷 31, 期 2, 页码 177-180出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jemermed.2005.08.020
关键词
hMG-CoA reductase inhibitors; rhabdomyolysis; drug toxicity; hepatitis; hyperlipidemia; cyclosporine; simvastatin; drug interactions
Simvastatin and other HMG-CoA reductase inhibitors (statins) are one of the most frequently prescribed class of medications in the United States, with over 15 million Americans taking these drugs. Relatively rare adverse effects related to the known toxic effects of these drugs are more common than generally realized. Clinically significant statin-induced rhabdomyolysis is an uncommon but life-threatening adverse effect. We describe a case of simvastatin-induced rhabdomyolysis. Current knowledge of the pharmacology of the HMG-CoA reductase inhibitors and the drug interactions that potentiate these adverse effects are discussed. The clinical features of rhabdomyolysis and current treatment recommendations are presented. (C) 2006 Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据